AstraZeneca PLC Director Declaration (9490S)
09 Noviembre 2023 - 9:00AM
UK Regulatory
TIDMAZN
RNS Number : 9490S
AstraZeneca PLC
09 November 2023
9 November 2023 15:00 BST
Director Declaration
AstraZeneca PLC (the Company) today announced that Philip
Broadley, senior independent Non-Executive Director of the Company,
has been appointed as Non-Executive Director and Chair designate to
the Board of Lancashire Holdings Limited with effect from 8
November 2023.
This announcement is made pursuant to Listing Rule 9.6.14 R
(2).
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development, and commercialisation of prescription medicines in
Oncology, Rare Diseases, and BioPharmaceuticals, including
Cardiovascular, Renal & Metabolism, and Respiratory &
Immunology. Based in Cambridge, UK, AstraZeneca operates in over
100 countries and its innovative medicines are used by millions of
patients worldwide. Please visit astrazeneca.com and follow the
Company on Twitter @AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNBKLFBXFLFFBF
(END) Dow Jones Newswires
November 09, 2023 10:00 ET (15:00 GMT)
Astrazeneca (LSE:0A4J)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Astrazeneca (LSE:0A4J)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024